← Back to Search

Gradual Reduction Program for Smokeless Tobacco Cessation

N/A
Waitlist Available
Led By Devon Noonan, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trialseeks to learn how to best help firefighters quit smokeless tobacco, by asking them to talk about their needs in focus groups. 40 firefighters will give insights to create a tailored cessation program.

Who is the study for?
This trial is for professional firefighters and first responders in North Carolina who are 18 or older, have used smokeless tobacco daily for the past year, and have access to a smartphone. It's not open to those under 18, non-firefighters/first responders, infrequent users of smokeless tobacco, or without smartphone access.
What is being tested?
The study aims to develop a mobile text/chat cessation program tailored for firefighters wanting to quit smokeless tobacco. Participants will be divided into two groups: one will receive the gradual reduction intervention via mobile messages; the other group won't get this support (control group).
What are the potential side effects?
Since this trial involves behavioral interventions with no medications involved, there are no direct medical side effects expected from participating. However, participants may experience psychological effects such as stress or anxiety during their attempt to quit.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: #EnufSnuff.TXT- First ResponderExperimental Treatment1 Intervention
Participants in this group will receive a mobile gradual smokeless tobacco reduction intervention
Group II: Enough Snuff InterventionActive Control1 Intervention
Participants in this group will receive tobacco cessation materials
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
#EnufSnuff.TXT- First Responder
2022
N/A
~60

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,011,963 Total Patients Enrolled
2 Trials studying Smokeless Tobacco Cessation
1,167 Patients Enrolled for Smokeless Tobacco Cessation
Duke UniversityLead Sponsor
2,451 Previous Clinical Trials
3,067,010 Total Patients Enrolled
3 Trials studying Smokeless Tobacco Cessation
662 Patients Enrolled for Smokeless Tobacco Cessation
Devon Noonan, PhDPrincipal InvestigatorDuke University
3 Previous Clinical Trials
662 Total Patients Enrolled
3 Trials studying Smokeless Tobacco Cessation
662 Patients Enrolled for Smokeless Tobacco Cessation

Media Library

Gradual Reduction to Quit Clinical Trial Eligibility Overview. Trial Name: NCT05111041 — N/A
Smokeless Tobacco Cessation Research Study Groups: #EnufSnuff.TXT- First Responder, Enough Snuff Intervention
Smokeless Tobacco Cessation Clinical Trial 2023: Gradual Reduction to Quit Highlights & Side Effects. Trial Name: NCT05111041 — N/A
Gradual Reduction to Quit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05111041 — N/A
~16 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top